USPTO serial 87136396
EDINBURGH MOLECULAR IMAGING
Reviewed by CopyMark Law Group
Reg. 5313900Status 710
- Filing date
- Status date
- Registration date
- Oct 17, 2017
- Examiner
- OEHRLEIN, STEFAN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with EDINBURGH MOLECULAR IMAGING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas W. Cole
THOMAS W. COLE ROBERTS MLOTKOWSKI SAFRAN COLE & CALDERON P.C.7918 JONES BRANCH DRIVESUITE 500MCLEAN, VA 22102Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical agents in the nature of contrast agents for use in molecular imaging and not for medical use; chemicals for use in molecular separation processes for use in industry and science, other than medical and veterinary use; chemical reagents for non-medical purposes for use in molecular imaging; contrast agents and chemicals for non-medical purposes for use in modifying the spectral or luminescent properties of other materials; luminescent chemicals for industrial purposes; fluorescent chemicals for industrial purposes; luminescent chemicals for industrial purposes for use as a luminescent label; fluorescent chemicals for industrial purposes for use as a fluorescent label; fluorogenic chemicals for industrial purposes; colorimetric chemicals for industrial purposes; biomolecule labelling kits consisting primarily of reagents for non-medical use in colorimetric or luminescent labelling; diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations for the treatment of cancer; contrast media for use in medical imaging; contrast media for in vivo imaging; contrasting agents for diagnostic ultrasound imaging; contrast media for use with imaging medical equipment, namely, contrast agents and chemicals for use in modifying the spectral or luminescent properties of other materials for medical use; contrast media for use with imaging medical equipment in the nature of luminescent chemicals for use as a luminescent label; biomolecule labelling kits comprising primarily diagnostic reagents for medicinal use for use in colorimetric or luminescent labelling; gases and gas mixtures for medical imaging use; diagnostic scanning agents for medical use; diagnostic reagents for medical use in the field of cancer; reagents for the detection and diagnosis of infections and diseases; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use | SECTION 8 - CANCELLED | — |
| 009 | Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking, supervision, life-saving and teaching apparatus and instruments, namely, medical laboratory research instruments for detecting pathogens, thermal imaging, DNA analysis; apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, blank optical recording discs; blank recordable CD-Rs, DVDs and USB flash drives; imaging apparatus, namely, microscopes; laser equipment for non-medical purposes, namely, laser microprobe for obtaining information on molecular structure of matter; electronic measuring apparatus and instruments, namely, microspectrophotometers; imaging instruments, namely, microscopes; scientific apparatus and instruments, namely, ultra-high vacuum chambers and parts thereof; data processing equipment; computer software for processing and displaying images on medical imaging machines; computer software for medical imaging equipment, namely, for interpreting and analysing the results of medical tests and CT scanners; computer application software for mobile phones, namely, software for processing and displaying images on medical imaging machines; computer application software for mobile phones, namely, software for interpreting and analysing the results of medical tests and CT scanners; downloadable electronic publications in the nature of reports and case studies in the field of molecular sciences and the detection, diagnosis, and treatment of diseases | SECTION 8 - CANCELLED | — |
| 010 | Surgical apparatus and instruments; medical apparatus and instruments for use in molecular imaging; medical equipment and devices, namely, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT) and fluorescent enabled imaging scanners and needle probe guides, and parts and fittings therefor; medical imaging apparatus; optical imaging apparatus for medical diagnostic use; medical radiation apparatus; medical imaging apparatus; diagnostic imaging apparatus for medical use; magnetic resonance imaging spectrometers for medical use; medical apparatus in the nature of apparatus for radionuclide imaging; urological imaging systems; magnetic resonance imaging (MRI) apparatus for medical diagnostic and medical purposes; probes for medical purposes, namely, fluorescent probes for imaging neutrophil elastase, fluorescent probes for imaging lung cancer, fluorescent probes for imaging dysplasia and fluorescent probes for imaging breast cancer; diagnostic imaging apparatus for medical use; magnetic resonance imaging instruments for medical purposes; medical apparatus for the detection and diagnosis of infections and diseases; medical apparatus for the detection and diagnosis of fibrosis and cancer; radioisotope apparatus for medical diagnostic use | SECTION 8 - CANCELLED | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, testing in the field of molecular sciences and the detection, diagnosis, and treatment of diseases; chemical research and analysis services; research relating to molecular sciences; analysis in the field of molecular biology; research and analysis in the field of molecular imaging and chemical reagents; scientific research for medical purposes in the area of cancerous diseases; information, consultancy and advisory services relating to all of the aforesaid services | SECTION 8 - CANCELLED | — |
| 044 | Medical services, namely, services for medical analysis; medical imaging services; human healthcare services; medical services for the diagnosis of conditions of the human body; information, consultancy and advisory services relating to all of the aforesaid services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Edinburgh Molecular Imaging Limited
- Other trademarks owned by Edinburgh Molecular Imaging Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EDINBURGH MOLECULAR IMAGING
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 3, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 17, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 17, 2017 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Sep 8, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 31, 2017 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Aug 31, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 31, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 31, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 31, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 25, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 8, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 21, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 13, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jun 12, 2017 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Jun 6, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 6, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 6, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 6, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 17, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 16, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 16, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 28, 2016 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Nov 28, 2016 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Nov 28, 2016 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Nov 25, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 17, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 16, 2016 | NWAP | NEW APPLICATION ENTERED | — |